The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

TAVI durability beyond five years: no alarms, but stay alert

EuroIntervention 2018;14:e380-e382 published online e-edition July 2018. DOI: 10.4244/EIJV14I4A67

1. Department of Cardiology, Rouen University Hospital, FHU REMOD-VHF, Rouen, France; 2. Normandie Univ, UNIROUEN, INSERM U1096, Rouen, France


Transcatheter aortic valve implantation (TAVI) has been widely adopted for the treatment of severe symptomatic aortic stenosis in elderly patients. Alain Cribier’s crazy concept of non-surgical valve implantation was to offer a life-saving treatment to the thousands of symptomatic patients with aortic stenosis who could not be operated on because of age and/or comorbidities1. His dream has come true. With the impressive continuous improvement in results, the technique is now the treatment of choice in elderly patients with few comorbidities and favourable transfemoral access. The evidence surpasses expectations: TAVI offers even better results than surgery for up ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Navigating the complexity of percutaneous coronary intervention in patients at high risk for bleeding